Connection

DANIEL MUSHER to Enterocolitis, Pseudomembranous

This is a "connection" page, showing publications DANIEL MUSHER has written about Enterocolitis, Pseudomembranous.
  1. Non-toxigenic Clostridium difficile to prevent recurrent C. difficile infection. Evid Based Med. 2016 Apr; 21(2):67.
    View in: PubMed
    Score: 0.486
  2. Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study. Clin Infect Dis. 2009 Feb 15; 48(4):e41-6.
    View in: PubMed
    Score: 0.301
  3. Treatment of clostridium difficile colitis in the critical care setting. Crit Care Clin. 2008 Apr; 24(2):279-91, viii.
    View in: PubMed
    Score: 0.283
  4. Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis. Am J Health Syst Pharm. 2007 Nov 15; 64(22):2359-63.
    View in: PubMed
    Score: 0.276
  5. Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide. J Antimicrob Chemother. 2007 Apr; 59(4):705-10.
    View in: PubMed
    Score: 0.263
  6. Nitazoxanide for the treatment of Clostridium difficile colitis. Clin Infect Dis. 2006 Aug 15; 43(4):421-7.
    View in: PubMed
    Score: 0.251
  7. An update on diagnosis, treatment, and prevention of Clostridium difficile-associated disease. Gastroenterol Clin North Am. 2006 Jun; 35(2):315-35.
    View in: PubMed
    Score: 0.249
  8. Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis. 2005 Sep; 5(9):549-57.
    View in: PubMed
    Score: 0.237
  9. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis. 2005 Jun 01; 40(11):1586-90.
    View in: PubMed
    Score: 0.231
  10. Clostridium difficile infection in patients with unexplained leukocytosis. Am J Med. 2003 Nov; 115(7):543-6.
    View in: PubMed
    Score: 0.209
  11. Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by clostridium difficile. Clin Infect Dis. 2002 Jun 15; 34(12):1585-92.
    View in: PubMed
    Score: 0.189
  12. Antibiotic stewardship and Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2008 Nov; 29(11):1096-7.
    View in: PubMed
    Score: 0.074
  13. Clostridium difficile lacks detectable superantigen activity. FEMS Immunol Med Microbiol. 2006 Jul; 47(2):275-7.
    View in: PubMed
    Score: 0.063
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.